Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
5.07 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.31 | 11752688 14514962 15322242 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.46 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.87 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.84 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.25 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
11.60 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
11.60 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.84 | 15885639 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.37 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.31 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.95 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
1.92 | 15093573 11325840 18323546 17388661 12006526 18234424 16978400 17020986 15136595 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.92 | 18855134 16273361 19115204 19410462 18629630 19244106 18351453 15565566 19221464 19066611 17893378 19487384 18815881 15668708 19011961 19200415 16202921 18984771 19084267 20065188 19142967 17049068 19189210 18425577 19189212 19289846 20135344 19288272 19155303 21138602 19059307 17261762 11161223 16873071 17242785 20005174 20544844 18997820 17440819 20390343 18821012 19103187 16818667 20859285 21152245 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.92 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.05 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.92 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
3.41 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
3.41 | 16924424 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
5.35 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
3.66 | 16201981 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.92 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.52 | 18850075 18670907 16120746 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.45 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
3.10 | 15861022 16105132 11677210 16919318 17110522 17333356 17681005 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.21 | 15340226 12621046 8697196 16354765 15668235 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 15322242 20055451 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
5.51 | 18093676 12388444 15643279 18483878 10498854 11948286 16614059 17010015 18372110 17979934 15276878 10700343 12913760 18295254 18433785 16651033 12161096 16413132 16989017 18710439 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.78 | 19031437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
4.33 | 15331540 10990075 11751995 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.29 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.76 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.60 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.99 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.70 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.42 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
10.24 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
10.24 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.24 | 20544844 16202921 19155303 17893378 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.33 | 10568697 9294722 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.63 | 11006010 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
8.79 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
8.79 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.41 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.87 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.99 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.64 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.36 | 20067830 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.98 | 11389073 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.12 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
5.45 | 11014644 16376943 15172196 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.47 | 10048152 11294989 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.71 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.66 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
6.05 | 14986274 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.31 | 15340226 16120746 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
4.07 | 16135485 17606976 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.57 | 8697196 16959395 15340226 18606429 16354765 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
2.00 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.23 | 16569931 16945680 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.85 | 16076520 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.81 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
7.55 | 7193160 16517039 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
7.55 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
5.37 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.37 | 12878042 12200463 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.66 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
3.31 | 18625569 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
3.62 | 10602166 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.61 | 17296974 17802794 17658394 18587576 18172266 17008537 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.32 | 10373061 |
MESH:D007965 |
Leukodystrophy, Globoid Cell |
marker/mechanism |
|
| |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
5.43 | 10052129 11830472 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.37 | 15342952 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.36 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.36 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
4.72 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.72 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.28 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.32 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.32 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
4.05 | 12854902 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.95 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
4.44 | 11911406 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.22 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.81 | 11731420 16827153 14580682 19196723 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
5.07 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.91 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.64 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
5.22 | 16388313 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.27 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.65 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.60 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
3.26 | 18854779 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.52 | 19200415 19196722 19189210 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.59 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
3.78 | 8761367 16115947 15176712 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
5.35 | 8761367 12837982 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.68 | 8291058 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
5.17 | 16517039 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.89 | 18093676 12161096 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
3.27 | 11332152 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
4.04 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.77 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.94 | 18163543 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.96 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.65 | 11896295 11118676 11222880 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
3.42 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.42 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.77 | 16919318 15861022 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.38 | 16636934 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.22 | 18990726 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
5.17 | 16636934 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.17 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
13.36 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
13.36 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.98 | 16517039 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.50 | 19457130 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
5.52 | 12837982 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.97 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.44 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.42 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
5.69 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
5.69 | 17572228 16712894 8653321 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.68 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.12 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.87 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.77 | 15886252 |